CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells

被引:243
作者
Sleeman, KE [1 ]
Kendrick, H [1 ]
Ashworth, A [1 ]
Isacke, CM [1 ]
Smalley, MJ [1 ]
机构
[1] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England
来源
BREAST CANCER RESEARCH | 2006年 / 8卷 / 01期
关键词
D O I
10.1186/bcr1371
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction Breast cancer is thought to arise in mammary epithelial stem cells. There is, therefore, a large amount of interest in identifying these cells. The breast is a complex tissue consisting of two epithelial layers ( an outer myoepithelial/basal layer and an inner luminal epithelial layer) as well as a large non-epithelial component ( fibroblasts, endothelial cells, lymphocytes, adipocytes, neurons and myocytes). The definitive identification of a mammary epithelial stem cell population is critically dependent on its purity. To date, this has been hampered by the lack of suitable markers to separate out the two epithelial layers, and to remove contaminating non-epithelial cells. Methods Mouse mammary glands were dissociated and stained with CD24. Cells were sorted into separate populations based on CD24 expression and assessed for luminal epithelial and myoepithelial/basal markers by direct fluorescent microscopy and real time PCR. The stem/progenitor potential of these cell populations was assessed in vivo by cleared mammary fat pad transplantation. Results Three populations of CD24 expressing cells were identified: CD24(Negative), CD24(Low) and CD24(High). Staining of these cells with cytokeratin markers revealed that these populations correspond to non-epithelial, myoepithelial/ basal and luminal epithelial cells, respectively. Cell identities were confirmed by quantitative PCR. Cleared mammary fat pad transplantation of these cell populations revealed that extensive mammary fat pad repopulation capacity segregates with the CD24(Low) cells, whilst CD24(High) cells have limited repopulation capacity. Conclusion Differential staining of mammary epithelial cells for CD24 can be used to simultaneously isolate pure populations of non-epithelial, myoepithelial/ basal and luminal epithelial cells. Furthermore, mammary fat pad repopulation capacity is enriched in the CD24(Low) population. As separation is achieved using a single marker, it will be possible to incorporate additional markers to further subdivide these populations. This will considerably facilitate the further analysis of mammary epithelial subpopulations, whilst ensuring high purity, which is key for understanding mammary epithelial stem cells in normal tissue biology and carcinogenesis.
引用
收藏
页数:6
相关论文
共 14 条
  • [1] Prospective identification of tumorigenic breast cancer cells
    Al-Hajj, M
    Wicha, MS
    Benito-Hernandez, A
    Morrison, SJ
    Clarke, MF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) : 3983 - 3988
  • [2] Alvi AJ, 2003, BREAST CANCER RES, V5, DOI [10.1186/bcr563, 10.1186/bcr547]
  • [3] Reducing mammary cancer risk through premature stem cell senescence
    Boulanger, CA
    Smith, GH
    [J]. ONCOGENE, 2001, 20 (18) : 2264 - 2272
  • [4] Mammary epithelial stem cells: Our current understanding
    Chepko, G
    Smith, GH
    [J]. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 1999, 4 (01) : 35 - 52
  • [5] A putative human breast stem cell population is enriched for steroid receptor-positive cells
    Clarke, RB
    Spence, K
    Anderson, E
    Howell, A
    Okano, H
    Potten, CS
    [J]. DEVELOPMENTAL BIOLOGY, 2005, 277 (02) : 443 - 456
  • [6] Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo
    Goodell, MA
    Brose, K
    Paradis, G
    Conner, AS
    Mulligan, RC
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) : 1797 - 1806
  • [7] The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk
    Jonker, JW
    Merino, G
    Musters, S
    van Herwaarden, AE
    Bolscher, E
    Wagenaar, E
    Mesman, E
    Dale, TC
    Schinkel, AH
    [J]. NATURE MEDICINE, 2005, 11 (02) : 127 - 129
  • [8] Stem cells, cancer, and cancer stem cells
    Reya, T
    Morrison, SJ
    Clarke, MF
    Weissman, IL
    [J]. NATURE, 2001, 414 (6859) : 105 - 111
  • [9] Stem cells and breast cancer: A field in transit
    Smalley, M
    Ashworth, A
    [J]. NATURE REVIEWS CANCER, 2003, 3 (11) : 832 - 844
  • [10] Smalley MJ, 1998, IN VITRO CELL DEV-AN, V34, P711